Short-term tolerability and dose toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors (NET)

被引:0
|
作者
Plaza, Bonilla J. [1 ]
Lorca, Martinez A. [1 ]
Martinez, Navarro T. [1 ]
Hernandez, Azpeitia P. [1 ]
Alonso-Gordoa, T. [1 ]
Molina-Cerrillo, J. [1 ]
Diez, Orduna M. D. P. [1 ]
机构
[1] Hosp Univ Ramon & Cajal, Madrid, Spain
关键词
prrt; 177lu; toxicity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
H04
引用
收藏
页码:137 / 137
页数:1
相关论文
共 50 条
  • [41] Therapy With 177Lu-DOTATATE: Clinical Implementation and Impact on Care of Patients With Neuroendocrine Tumors
    Kendi, A. Tuba
    Halfdanarson, Thorvardur R.
    Packard, Annie
    Dundar, Ayca
    Subramaniam, Rathan M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (02) : 309 - 317
  • [42] 177Lu-DOTATATE (PRRT) in the treatment of patients with gastroenteropancreatic neuroendocrine tumors (GEPNETs) versus other tumors
    Jimenez-Fonseca, P.
    Pubul, V
    Bello, P.
    Riesco-Martinez, M. D. C.
    Aller, J.
    Alonso, Garcia P.
    Caballero, E.
    Custodio, A.
    Centeno, Garcia R.
    Teule, A.
    Casanovas, Mitjavila M.
    Carmona-Bayonas, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 147 - 147
  • [43] COST-EFFECTIVENESS ANALYSIS OF RE-TREATMENT WITH 177LU-DOTATATE VERSUS NO RE-TREATMENT WITH 177LU-DOTATATE IN PATIENTS WITH PROGRESSIVE MIDGUT NEUROENDOCRINE TUMORS
    Leeuwenkamp, O.
    Mahon, R.
    Singh, M. K.
    Khare, A.
    VALUE IN HEALTH, 2020, 23 : S446 - S446
  • [44] Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
    Parghane, Rahul V.
    Talole, Sanjay
    Prabhash, Kumar
    Basu, Sandip
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (06) : 428 - 435
  • [45] 177Lu-DOTATATE therapy in advanced pancreatic neuroendocrine tumors: data from 187 patients of the national registry SEPTRALU
    Mitjavila-Casanovas, M.
    Bello, P.
    Pubul, V.
    Garcia-Burillo, A.
    Hernando, J.
    Alonso-Farto, J.
    Arbizu, J.
    Rodeno, E.
    Estorch, M.
    Gajate, P.
    Marin, D.
    Garcia-Canamaque, L.
    Llana, B.
    Miguel, B.
    Castellon, M.
    Caballero, E.
    Coronado, M.
    Cano, J.
    Repetto, A.
    Vercher, J.
    Muros, A.
    Garcia-Alonso, P.
    del Olmo, M.
    Carmona-Bayonas, A.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S247 - S247
  • [46] Safety of 177Lu-DOTATATE in patients with advanced neuroendocrine tumors: Data from a US expanded access program.
    Auerbach, Martin S.
    Wolin, Edward M.
    Nassiri, Val
    Broberg, Per
    El-Haddad, Ghassan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants
    Fross-Baron, Katarzyna
    Garske-Roman, Ulrike
    Welin, Staffan
    Granberg, Dan
    Eriksson, Barbro
    Khan, Tanweera
    Sandstrom, Mattias
    Sundin, Anders
    NEUROENDOCRINOLOGY, 2021, 111 (04) : 330 - 343
  • [48] The HSP90-inhibitor Onalespib Potentiates 177Lu-Dotatate Treatment of Neuroendocrine Tumors
    Lundsten, S.
    Mortensen, A.
    Makiniemi, A.
    Spiegelberg, D.
    Stenerlow, B.
    Nestor, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S326 - S326
  • [49] 177Lu-DOTATATE in advanced neuroendocrine tumours: real word data from SEPTRALU registry
    Mitjavila Casanovas, M.
    Field, C.
    Bello, P.
    Nogareda Seoane, Z.
    Garcia-Canamaque, L.
    Arbizu, J.
    Rotger, A.
    Gajate, P.
    Castellon, M.
    Muros, M.
    Teule, A.
    Repetto, A.
    Miguel Martinez, M.
    Estorch, M.
    Jimenez Fonseca, P.
    Carmona-Bayona, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S93 - S93
  • [50] Extrahepatic 68Ga-DOTATATE-Avid Tumor Volume and serum Chromogranin A Predict Short-Term Outcome of 177Lu-DOTATATE in Late-Stage Metastatic Gastroenteropancreatic Neuroendocrine Tumors
    Song, Hong
    Kunz, Pamela
    Franc, Benjamin
    Moradi, Farshad
    Fisher, George
    Aparici, Carina Mari
    Iagaru, Andrei
    Davidzon, Guido
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61